Clinical Trial

A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

Name: A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR) — clinical trial record (NCT07459556)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.

Trial Details

NCT Number	NCT07459556
Lead Sponsor	Chengdu Kangnuoxing Biopharma,Inc.
Conditions	SAR
Enrollment	400 participants
Start Date	2026-03
Primary Completion	2027-12 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-09